Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatic Safety of Raltegravir vs Efavirenz in HIV/HCV Coinfection
NCT01147107Phase 4Completed
- Sponsor
- University of Hawaiʻi
- Start
- Feb 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by University of Hawaiʻi. Started Feb 2014; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01147107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01147107.